Next Generation News and Research

RSS

Radiological imaging system that will give medics a clearer view inside the human body

EUREKA project E! 2427 PERMON is developing a radiological imaging system that will give medics a clearer view inside the human body by accurately monitoring organ blood flow during operations. This essential information will lead to an increase in techniques such as laser surgery over more invasive methods.

2 Jun 2004

Malaria, Africa's biggest killer

It's Africa's biggest killer, but it's not HIV. It causes economic losses of US$12 billion per year, but it's not a war. And it has slowed African economic growth by around 1.3 per cent per annum, but it’s not a famine.

2 Jun 2004

New 100 teraflop supercomputer will help simulation of brain seizures

The U.S. Department of Energy's Argonne National Laboratory will play a major role in the development of a new national computational science facility aimed at deploying a supercomputer capable of sustained performance of 100 trillion floating-point operations per second (teraflops) by 2007.

21 May 2004

Connetics issued U.S. patent for emollient-foam technology

Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, announced today that on May 4, 2004 the United States Patent and Trademark Office (USPTO) issued to Connetics Patent No. 6,730,288 B1. The patent has 7 independent product claims, and covers a pharmaceutical aerosol foam composition having occlusive capability.

17 May 2004

Genomed treatment helps bald eagles with West Nile virus encephalitis

GenoMed, Inc. a Next Generation Disease Management company that uses its expertise in genomics to improve clinical outcomes in as many species as possible, announced today that two non-profit groups which care for wild birds with West Nile virus encephalitis, including American bald eagles, will be using the Company's patent-pending treatment this season.

13 May 2004

Thoratec gets FDA approval for increased enrollment and Medicare expansion for heart pump

Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).

12 May 2004

GenoMed adds to management team

GenoMed, Inc., a Next Generation Disease Management™ company that uses its expertise in genes to improve patient outcomes, said today that it has hired three additional full-time employees: a Chief Financial Officer, a Vice President for Marketing, and a Chief Technical Officer.

11 May 2004

The world generic drug market is expected to grow 10-15% annually

Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.

6 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

Intranasal influenza vaccine may help induce broader immunity in children than the traditional flu shot

MedImmune, Inc. has announced clinical data showing that a live, attenuated intranasal influenza vaccine (LAIV) may help induce broader immunity in children against drifted influenza strains when compared to the traditional flu shot (TIV).

2 May 2004

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.

28 Apr 2004

Experimental smallpox DNA vaccine

In the first successful study of its kind, scientists have shown that a DNA-based vaccine for smallpox can protect nonhuman primates from monkeypox, a disease that resembles smallpox in humans.

27 Apr 2004

A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States

A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.

27 Apr 2004

Spice turmeric corrects the cystic fibrosis defect

Scientists at The Hospital for Sick Children (Sick Kids) and Yale University School of Medicine have found that a compound in the spice turmeric corrects the cystic fibrosis defect in mice. This research is reported in the April 23, 2004 issue of the journal Science.

24 Apr 2004

Pierre Pettigrew outlines plan of action for health care reforms

Canadians have a "right" to know how long they have to wait to receive medical treatment, Health Minister Pierre Pettigrew said yesterday.

21 Apr 2004

Genetic connection between humans, mice and dogs

The discovery that humans are genetically close to mice and dogs might make people develop greater respect for life, J. Craig Venter, a major contributor to the historic mapping of the human genome, said.

16 Apr 2004

Researchers find next generation of medications to help schizophrenics

Researchers at Duke University Medical Center have found that a new generation of medications called "atypical antipsychotics" can significantly lower the risk of violent behavior in people with schizophrenia who are being treated in community-based centers.

13 Apr 2004

The Cambridge-MIT Institute has launched a project to tackle the bottlenecks that slow development of new drugs

The Next-Generation Drug Discovery Community will unite researchers at Cambridge University and MIT with partners from the information technology, pharmaceutical and biotechnology industries to find ways to speed up development of the next generation of drugs--particularly those that treat diseases with complex causes such as cancers, arthritis, multiple sclerosis and diabetes.

7 Apr 2004

Collaboration to create a series of small molecule drugs leads against a Takeda target

Array BioPharma Inc. today announced the commencement of a drug discovery collaboration with Takeda Chemical Industries, Ltd. to create a series of small molecule drug leads against a Takeda target. This collaboration is in addition to Array's existing research agreement with Takeda that began in 2001.

5 Apr 2004

GenVec malaria vaccine initiative and the U.S. Naval Medical Research Center has announced partnership for malaria vaccine

GenVec, Inc., PATH's Malaria Vaccine Initiative (MVI), and the U.S. Naval Medical Research Center (NMRC) today announced a dynamic partnership to assess whether five malaria antigens, or proteins, can generate strong immune responses alone or in combination. This partnership will advance and expand the ongoing malaria vaccine development program between GenVec and NMRC. Malaria is one of the world's three leading infectious disease killers.

31 Mar 2004